Patents Assigned to Mederis Diabetes, LLC
-
Publication number: 20250136656Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: ApplicationFiled: November 11, 2024Publication date: May 1, 2025Applicant: Mederis Diabetes LLCInventor: John J. NESTOR
-
Publication number: 20240424062Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: ApplicationFiled: February 26, 2024Publication date: December 26, 2024Applicant: Mederis Diabetes LLCInventor: John J. Nestor
-
Patent number: 11911447Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: GrantFiled: June 16, 2021Date of Patent: February 27, 2024Assignee: Mederis Diabetes LLCInventor: John J. Nestor
-
Publication number: 20230218564Abstract: The disclosure provides peptide products comprising a peptide covalently attached to a surfactant moiety which have improved properties, including increased duration of action and bioavailability. The peptide products are useful for treating insulin resistance, diabetes, obesity, metabolic syndrome and cardiovascular diseases, and conditions associated therewith, such as NASH and PCOS.Type: ApplicationFiled: December 20, 2022Publication date: July 13, 2023Applicant: Mederis Diabetes LLCInventor: John J Nestor
-
Publication number: 20220362345Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: ApplicationFiled: June 16, 2021Publication date: November 17, 2022Applicant: Mederis Diabetes LLCInventor: John J. Nestor
-
Patent number: 11065304Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: GrantFiled: November 20, 2013Date of Patent: July 20, 2021Assignee: Mederis Diabetes, LLCInventor: John J. Nestor
-
Publication number: 20210077629Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: ApplicationFiled: September 23, 2019Publication date: March 18, 2021Applicant: Mederis Diabetes LLCInventor: John J. NESTOR
-
Publication number: 20200352900Abstract: The disclosure provides peptide products comprising a peptide covalently attached to a surfactant moiety which have improved properties, including increased duration of action and bioavailability. The peptide products are useful for treating insulin resistance, diabetes, obesity, metabolic syndrome and cardiovascular diseases, and conditions associated therewith, such as NASH and PCOS.Type: ApplicationFiled: January 3, 2019Publication date: November 12, 2020Applicant: Mederis Diabetes LLCInventor: John J Nestor
-
Publication number: 20200289653Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: ApplicationFiled: March 21, 2020Publication date: September 17, 2020Applicant: Mederis Diabetes LLCInventor: John J. Nestor
-
Publication number: 20200277351Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: ApplicationFiled: January 21, 2020Publication date: September 3, 2020Applicant: Mederis Diabetes LLCInventor: John J. NESTOR
-
Patent number: 10577405Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: GrantFiled: November 21, 2017Date of Patent: March 3, 2020Assignee: Mederis Diabetes LLCInventor: John J. Nestor
-
Patent number: 10471127Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: GrantFiled: May 17, 2012Date of Patent: November 12, 2019Assignee: Mederis Diabetes, LLCInventor: John J. Nestor
-
Patent number: 10420844Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: GrantFiled: March 6, 2018Date of Patent: September 24, 2019Assignee: Mederis Diabetes LLCInventor: John J. Nestor
-
Publication number: 20140349928Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.Type: ApplicationFiled: May 17, 2012Publication date: November 27, 2014Applicant: Mederis Diabetes, LLCInventor: John J. Nestor
